Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: Stage migration and predictability

Annals of Surgical Oncology

Volumn 14, Issue 5, 2007, Pages 1551-1559

  Lang, Brian ^a   Lo, Chung Yau ^a   Chan, Wai Fan ^a   Lam, King Yin ^b   Wan, Koon Yat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Differentiated thyroid carcinoma; Follicular thyroid carcinoma; Papillary thyroid carcinoma; Risk stratification; Staging; TNM

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA; ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 34249100947     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9242-2     Document Type: Article

References (26)

1. Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin 2005; 55:242-58
2. Byar DP, Green SB, Dor P, Williams ED, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M. A prognostic index for thyroid carcinoma: a study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979; 15:1033-41
3. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104(6):947-53
4. Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. Cancer 1998; 83:1012-21
5. Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH. The process for continuous improvement of the TNM classification. Cancer 2004; 100:1-5
6. Comparison Guide. AJCC cancer staging manual, fifth vs sixth edition. Available: http://www.cancerstaging.org/products/ajccproducts.html [accessed 11th February 2005]
7. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 2004; 89:3713-20
8. Dobert N, Menzel C, Oeschger S, Grünwald. Differentiated thyroid carcinoma: the new UICC sixth edition TNM classification system in a retrospective analysis of 169 patients. Thyroid 2004; 14(1):65-70
9. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 2006; 30:1-7
10. Sherman SI. Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma. Semin Surg Oncol 1999; 16:12-5
11. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004; 114:393-402
12. Sobin LH, Wittekind Ch. (1997) UICC TNM classification of malignant tumours, 5th edn. New York: Wiley-Liss
13. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. (2002) AJCC cancer staging handbook: TNM classification of malignant tumors, 6th edn. New York: Springer-Verlag
14. Wittekind Ch, Greene FL, Henson DE, Hutter RVP, Sobin LH. (2003) TNM supplement: a commentary on uniform use, 3rd edn. New York: Wiley-Liss
15. DeLellis RA, Lloyd RV, Heitz PU, Eng C. World Health Organization classification of tumours: pathology and genetics of tumours of endocrine organs. France: IARC (International Agency for Research on Cancer) Press; 2004
16. Schemper M, Stare J. Explained variation in survival analysis. Stat Med 1996; 15:1999-2012
17. Greene FL. TNM: Our language of cancer. CA Cancer J Clin 2004; 54:129-30
18. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B. A comparison of different staging systems. Predictability of patient outcome. Thyroid carcinoma as an example. Cancer 1997; 79:2414-23
19. Passler C, Prager G, Scheuba C, Kaserer K, Zettinig G, Niederle B. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 2003; 207(2):227-34
20. Yildirim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005; 200:378-92
21. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metabol 1990:71:414-24
22. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114(6):1050-8
23. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-28
24. Goropoulos A, Karamoshos K, Christodoulou A, Ntitsias T, Paulou K, Samaras A, Xirou P, Efstratiou I. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J Surg 2004; 28(12):1275-81
25. Pereira JA, Jimeno J, Miquel J, Igesias M, Munne A, Sancho JJ, Sitges-Serra A. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 2005; 138(6):1095-101
26. Sobin LH. TNM: principles, history, and relation to other prognostic factors. Cancer 2001; 91(8):1589-92